Fundraising FoxEilean Therapeutics
1 known investors
Find your way into Eilean Therapeutics
Sign up to see every warm intro you have to Eilean Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eilean Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eilean Therapeutics is a small molecule oncology drug discovery company developing pan-variant therapies that target resistance mechanisms in hematologic malignancies. Founded in 2022, it focuses on creating first- and best-in-class treatments for blood cancers that have developed resistance to existing therapies.
Founders & leadership
Investors · 1
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Eilean Therapeutics do?
- Eilean Therapeutics is a small molecule oncology drug discovery company developing pan-variant therapies that target resistance mechanisms in hematologic malignancies. Founded in 2022, it focuses on creating first- and best-in-class treatments for blood cancers that have developed resistance to existing therapies.
- Who founded Eilean Therapeutics?
- Eilean Therapeutics was founded by Iain Dukes, John Byrd.
- Who are Eilean Therapeutics's investors?
- Eilean Therapeutics's investors include OrbiMed.